TRIVIAL SYMPATHOMIMETIC TOXIDROME FOLLOWING MASSIVE INGESTION OF CONTROLLED-RELEASE METHYLPHENIDATE

被引:0
作者
King, Alexandra
Babcock, Cody
Bachman, George
Hon, Stephanie
Colombo, Christopher
机构
[1] Eisenhower Army Med Ctr, Ft Gordon, GA USA
[2] Georgia Poison Ctr, Atlanta, GA USA
[3] Eisenhower Army Med Ctr Ft Gordon, Evans, GA USA
关键词
D O I
10.1097/01.ccm.0000528933.84007.f0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
926
引用
收藏
页码:446 / 446
页数:1
相关论文
共 45 条
[21]   Effects of a controlled-release formulation of methylphenidate on vital signs in school-aged youths with attention-deficit/hyperactivity disorder [J].
Biederman, J ;
Wilens, TE .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 :S414-S414
[22]   Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS® (methylphenidate HCl) formulation [J].
Modi, NB ;
Lindemulder, B ;
Gupta, SK .
JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (04) :379-388
[23]   MULTIPLE-DOSE PHARMACOKINETICS OF DIAZEPAM FOLLOWING ONCE-DAILY ADMINISTRATION OF A CONTROLLED-RELEASE CAPSULE [J].
WILLS, RJ ;
COLBURN, WA .
THERAPEUTIC DRUG MONITORING, 1983, 5 (04) :423-426
[24]   A randomized trial of controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty [J].
Cheville, A ;
Chen, A ;
Oster, G ;
McGarry, L ;
Narcessian, E .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2001, 83A (04) :572-576
[25]   The use of controlled-release versus scheduled oxycodone in the immediate postoperative period following total joint arthroplasty [J].
Kerpsack, JM ;
Fankhauser, RA .
ORTHOPEDICS, 2005, 28 (05) :491-494
[26]   The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study [J].
Dymowski, Alicia R. ;
Ponsford, Jennie L. ;
Owens, Jacqueline A. ;
Olver, John H. ;
Ponsford, Michael ;
Willmott, Catherine .
CLINICAL REHABILITATION, 2017, 31 (06) :733-741
[27]   Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: Results of a double-blind, placebo-controlled crossover study [J].
Jain, Umesh ;
Hechtman, Lily ;
Weiss, Margaret ;
Ahmed, Tahira S. ;
Reiz, Joseph L. ;
Donnelly, Graeme A. E. ;
Harsanyi, Zoltan ;
Darke, Andrew C. .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) :268-277
[28]   ALVEOLAR BONE AUGMENTATION FOLLOWING THE LOCAL-ADMINISTRATION OF PROSTAGLANDIN-E(1) BY CONTROLLED-RELEASE PELLETS [J].
MILLER, SC ;
MARKS, SC .
BONE, 1993, 14 (03) :587-593
[29]   Nutrition and attention deficit hyperactivity disorder: developmental follow-up of the anthropometric variables of a group of patients receiving treatment with osmotic controlled-release methylphenidate [J].
Dura-Trave, Teodoro ;
Eugenia Yoldi-Petri, M. ;
Zardoya-Santos, Patricia .
REVISTA DE NEUROLOGIA, 2011, 53 (05) :257-264
[30]   RELATIVE ABSORPTION OF DISOPYRAMIDE AS DETERMINED BY LIQUID-CHROMATOGRAPHY FOLLOWING ACUTE ADMINISTRATION OF STANDARD CAPSULES AND CONTROLLED-RELEASE TABLETS [J].
GRAFFNER, C ;
LAGERSTROM, POG ;
LUNDBORG, PNG ;
RONN, OF .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1981, 19 (09) :414-420